Abstract
Primary writing tremor is a rare motor disorder in which tremor occurs primarily during writing and is not accompanied by other neurological symptoms and/or signs. Its etiopathogenesis is unknown, and treatment approaches remain largely empirical. Based on the effectiveness of botulinum toxin injections in writing dysfunction, we effectively used botulinum toxin type A for the treatment of primary writing tremor in a series of patients seen over a period of 5 years. Of the 5 patients, four received injections and reported significant and sustained treatment benefit for a period of at least 1 year. One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl.
| Original language | English |
|---|---|
| Pages (from-to) | 364-367 |
| Number of pages | 4 |
| Journal | Clinical Neuropharmacology |
| Volume | 29 |
| Issue number | 6 |
| DOIs | |
| State | Published - Nov 1 2006 |
Fingerprint
Keywords
- Botulinum toxin type A
- Case series
- Clinical characteristics
- Dystonia
- Primary writing tremor
- Treatment
ASJC Scopus subject areas
- Pharmacology (medical)
- Clinical Neurology
- Neuroscience(all)
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Treatment of Primary Writing Tremor with Botulinum Toxin Type a Injections : Report of a Case Series. / Papapetropoulos, Spiridon; Singer, Carlos.
In: Clinical Neuropharmacology, Vol. 29, No. 6, 01.11.2006, p. 364-367.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment of Primary Writing Tremor with Botulinum Toxin Type a Injections
T2 - Report of a Case Series
AU - Papapetropoulos, Spiridon
AU - Singer, Carlos
PY - 2006/11/1
Y1 - 2006/11/1
N2 - Primary writing tremor is a rare motor disorder in which tremor occurs primarily during writing and is not accompanied by other neurological symptoms and/or signs. Its etiopathogenesis is unknown, and treatment approaches remain largely empirical. Based on the effectiveness of botulinum toxin injections in writing dysfunction, we effectively used botulinum toxin type A for the treatment of primary writing tremor in a series of patients seen over a period of 5 years. Of the 5 patients, four received injections and reported significant and sustained treatment benefit for a period of at least 1 year. One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl.
AB - Primary writing tremor is a rare motor disorder in which tremor occurs primarily during writing and is not accompanied by other neurological symptoms and/or signs. Its etiopathogenesis is unknown, and treatment approaches remain largely empirical. Based on the effectiveness of botulinum toxin injections in writing dysfunction, we effectively used botulinum toxin type A for the treatment of primary writing tremor in a series of patients seen over a period of 5 years. Of the 5 patients, four received injections and reported significant and sustained treatment benefit for a period of at least 1 year. One patient declined botulinum toxin injections and responded moderately when treated with trihexyphenidyl.
KW - Botulinum toxin type A
KW - Case series
KW - Clinical characteristics
KW - Dystonia
KW - Primary writing tremor
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=33750898278&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750898278&partnerID=8YFLogxK
U2 - 10.1097/01.WNF.0000236765.00785.9C
DO - 10.1097/01.WNF.0000236765.00785.9C
M3 - Article
C2 - 17095901
AN - SCOPUS:33750898278
VL - 29
SP - 364
EP - 367
JO - Clinical Neuropharmacology
JF - Clinical Neuropharmacology
SN - 0362-5664
IS - 6
ER -